PubRank

M Cornberg

Author PubWeight™ 40.75‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Treatment of acute hepatitis C with interferon alfa-2b. N Engl J Med 2001 7.71
2 Treating viral hepatitis C: efficacy, side effects, and complications. Gut 2006 3.71
3 The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm. J Viral Hepat 2014 2.23
4 Detection of low HCV viraemia by repeated HCV RNA testing predicts treatment failure to triple therapy with telaprevir. Aliment Pharmacol Ther 2013 2.21
5 [Prophylaxis, diagnosis and therapy of hepatitis C virus (HCV) infection: the German guidelines on the management of HCV infection]. Z Gastroenterol 2010 1.76
6 Historical epidemiology of hepatitis C virus (HCV) in selected countries. J Viral Hepat 2014 1.68
7 Strategies to manage hepatitis C virus (HCV) disease burden. J Viral Hepat 2014 1.67
8 Expression of leptin and leptin receptor isoforms in the human stomach. Gut 2000 1.22
9 The clinical significance of drug-drug interactions in the era of direct-acting anti-viral agents against chronic hepatitis C. Aliment Pharmacol Ther 2013 1.19
10 [Expert opinion on boceprevir- and telaprevir-based triple therapies of chronic hepatitis C]. Z Gastroenterol 2012 1.17
11 Proinflammatory cytokines trigger MUC gene expression and mucin release in the intestinal cancer cell line LS180. Inflamm Res 2000 1.11
12 Regulation of cytosolic free calcium concentration by extracellular nucleotides in human hepatocytes. Am J Physiol 1999 1.00
13 Cross-genotype-reactivity of the immunodominant HCV CD8 T-cell epitope NS3-1073. Vaccine 2008 0.99
14 The privacy of T cell memory to viruses. Curr Top Microbiol Immunol 2006 0.98
15 Isolated anti-HBV core phenotype in anti-HCV-positive patients is associated with hepatitis C virus replication. Clin Microbiol Infect 2004 0.97
16 Fulminant hepatic failure due to chemotherapy-induced hepatitis B reactivation: role of rituximab. Z Gastroenterol 2010 0.90
17 Clearance of chronic HCV infection during acute delta hepatitis. Infection 2007 0.85
18 Significance of the caspase family in Helicobacter pylori induced gastric epithelial apoptosis. Helicobacter 2002 0.83
19 Development and evaluation of a baseline-event-anticipation score for hepatitis delta. J Viral Hepat 2014 0.82
20 Morphological and molecular characterization of human gastric mucous cells in long-term primary culture. Pflugers Arch 1998 0.82
21 Current and future treatment of hepatitis C. Indian J Gastroenterol 2001 0.82
22 The German Hep-Net acute hepatitis C cohort: impact of viral and host factors on the initial presentation of acute hepatitis C virus infection. Z Gastroenterol 2009 0.81
23 Hepatitis C virus core antigen testing in liver and kidney transplant recipients. J Viral Hepat 2013 0.81
24 [Hepatitis associated cryoglobulinemia]. Internist (Berl) 2008 0.80
25 Making sense of muscle fatigue and liver lesions. Z Gastroenterol 2007 0.79
26 Impaired TRAIL-dependent cytotoxicity of CD1c-positive dendritic cells in chronic hepatitis C virus infection. J Viral Hepat 2008 0.78
27 Pneumococcal meningitis during antiviral treatment with interferon and ribavirin in a splenectomized patient with chronic hepatitis C - do not miss vaccination before starting therapy. Z Gastroenterol 2008 0.78
28 [Knowledge and management of hepatitis B virus infected patients in Germany]. Dtsch Med Wochenschr 2012 0.78
29 Treatment of chronic hepatitis C with consensus interferon in relapsers and non-responders to interferon-based therapy. Hepatogastroenterology 2007 0.77
30 Hepatitis C virus-specific T cell responses against conserved regions in recovered patients. Vaccine 2009 0.77
31 [Hepatitis E virus infection: a paradigm shift?]. Dtsch Med Wochenschr 2010 0.76
32 [German guidelines on diagnosis and therapy of hepatitis B]. Dtsch Med Wochenschr 2007 0.75
33 [Diagnostics and therapy of hepatitis]. Internist (Berl) 2009 0.75
34 [PEG-interferons: significance for the treatment of viral hepatitis B and C]. Dtsch Med Wochenschr 2001 0.75
35 [Which treatment options are validated for chronic viral hepatitis?]. Internist (Berl) 2013 0.75
36 [Paradigmatic change in treatment of viral hepatitides]. Dtsch Med Wochenschr 2012 0.75
37 [Costs of guideline-based treatment of hepatitis B patients in Germany]. Z Gastroenterol 2012 0.75